Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001451980-11-000010
Filing Date
2011-03-15
Accepted
2011-03-14 18:26:32
Documents
7
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 10-K FILING - 2010 filing10k.htm 10-K 3302152
2 EXHIBIT 23.1 exhibit231.htm EX-23.1 6308
3 EXHIBIT 31.1 exhibit311.htm EX-31.1 12682
4 EXHIBIT 31.2 exhibit312.htm EX-31.2 12927
5 EXHIBIT 32.1 exhibit321.htm EX-32.1 9042
6 EXHIBIT 32.2 exhibit322.htm EX-32.2 8999
7 GRAPHIC IMAGE filing10k.jpg GRAPHIC 20008
  Complete submission text file 0001451980-11-000010.txt   3380833
Mailing Address BECK SCIENCE CENTER 8 HARTOM STREET, HAR HOTZVIM JERUSALEM L3 97775
Business Address BECK SCIENCE CENTER 8 HARTOM STREET, HAR HOTZVIM JERUSALEM L3 97775 972-2-548-6555
BIOCANCELL THERAPEUTICS INC. (Filer) CIK: 0001451980 (see all company filings)

EIN.: 204630076
Type: 10-K | Act: 34 | File No.: 000-53708 | Film No.: 11686674
SIC: 2834 Pharmaceutical Preparations